Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
WINT Windtree Therapeutics Inc
- Stocks
- Healthcare
- NASDAQ: WINT
Price (delayed)
$0.828
Market cap
$3.03M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$933.98
Enterprise value
$3.43M
Windtree Therapeutics, Inc. is advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders to treat patients in moments of crisis. Using new clinical approaches, Windtree is developing a multi-asset
Highlights
WINT's EPS is up by 49% year-on-year
The equity has declined by 33% year-on-year but it has increased by 2.9% since the previous quarter
WINT's debt is down by 13% QoQ but it is up by 6% YoY
The company's net income has shrunk by 169% YoY
Windtree Therapeutics's quick ratio has shrunk by 65% YoY and by 42% QoQ
Key stats
What are the main financial stats of WINT
Market
Valuations
Earnings
Shares outstanding
3.66M
Market cap
$3.03M
Enterprise value
$3.43M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.12
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$25.82M
Net income
-$16.05M
EBIT
-$15.93M
EBITDA
-$15.45M
Free cash flow
-$14.86M
Per share
Balance sheet
Liquidity
EPS
-$933.98
EPS diluted
-$933.98
Free cash flow per share
-$13.65
Book value per share
$6.64
Revenue per share
$0
TBVPS
$2.42
Total assets
$26.77M
Total liabilities
$15.44M
Debt
$1.58M
Equity
$10.29M
Working capital
-$4.88M
Debt to equity
0.15
Current ratio
0.25
Quick ratio
0.18
Net debt/EBITDA
-0.03
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-72.9%
Return on equity
-294.4%
Return on invested capital
N/A
Return on capital employed
-78.5%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
WINT stock price
How has the Windtree Therapeutics stock price performed over time
Intraday
-0.24%
1 week
-2.84%
1 month
-26.73%
1 year
-80.74%
YTD
137.05%
QTD
-34.29%
Financial performance
How have Windtree Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$25.82M
Net income
-$16.05M
Gross margin
N/A
Net margin
N/A
The company's net income has shrunk by 169% YoY
The operating income has contracted by 24% YoY
Price vs fundamentals
How does WINT's price correlate with its fundamentals
Growth
What is Windtree Therapeutics's growth rate over time
Valuation
What is Windtree Therapeutics stock price valuation
P/E
N/A
P/B
0.12
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
WINT's EPS is up by 49% year-on-year
The price to book (P/B) is 83% less than the 5-year quarterly average of 0.7 and 60% less than the last 4 quarters average of 0.3
The equity has declined by 33% year-on-year but it has increased by 2.9% since the previous quarter
Efficiency
How efficient is Windtree Therapeutics business performance
Dividends
What is WINT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for WINT.
Financial health
How did Windtree Therapeutics financials performed over time
The company's total assets is 73% higher than its total liabilities
Windtree Therapeutics's quick ratio has shrunk by 65% YoY and by 42% QoQ
The current ratio has dropped by 63% year-on-year and by 44% since the previous quarter
WINT's debt is 85% lower than its equity
The company's debt to equity has surged by 50% YoY but it fell by 17% QoQ
The equity has declined by 33% year-on-year but it has increased by 2.9% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.